These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35069223)

  • 1. Genetic Blockade of NAAA Cell-specifically Regulates Fatty Acid Ethanolamides (FAEs) Metabolism and Inflammatory Responses.
    Xie X; Li Y; Xu S; Zhou P; Yang L; Xu Y; Qiu Y; Yang Y; Li Y
    Front Pharmacol; 2021; 12():817603. PubMed ID: 35069223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
    Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
    Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the discovery of N-acylethanolamine acid amidase inhibitors.
    Bandiera T; Ponzano S; Piomelli D
    Pharmacol Res; 2014 Aug; 86():11-7. PubMed ID: 24798679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-restricted anti-inflammatory activities of a N-acylethanolamine acid amidase (NAAA) inhibitor F215.
    Li Y; Zhou P; Chen H; Chen Q; Kuang X; Lu C; Ren J; Qiu Y
    Pharmacol Res; 2018 Jun; 132():7-14. PubMed ID: 29572189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation.
    Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
    Pharmacol Res; 2022 Nov; 185():106491. PubMed ID: 36244543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as
    Zhou P; Xiang L; Zhao D; Ren J; Qiu Y; Li Y
    Medchemcomm; 2019 Feb; 10(2):252-262. PubMed ID: 30931090
    [No Abstract]   [Full Text] [Related]  

  • 7. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
    Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationship (SAR) of 2-methyl-4-oxo-3-oxetanylcarbamic acid esters, a class of potent N-acylethanolamine acid amidase (NAAA) inhibitors.
    Ponzano S; Bertozzi F; Mengatto L; Dionisi M; Armirotti A; Romeo E; Berteotti A; Fiorelli C; Tarozzo G; Reggiani A; Duranti A; Tarzia G; Mor M; Cavalli A; Piomelli D; Bandiera T
    J Med Chem; 2013 Sep; 56(17):6917-34. PubMed ID: 23991897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α.
    Yang L; Li L; Chen L; Li Y; Chen H; Li Y; Ji G; Lin D; Liu Z; Qiu Y
    Sci Rep; 2015 Aug; 5():13565. PubMed ID: 26310614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different roles for the acyl chain and the amine leaving group in the substrate selectivity of
    Ghidini A; Scalvini L; Palese F; Lodola A; Mor M; Piomelli D
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1411-1423. PubMed ID: 34256657
    [No Abstract]   [Full Text] [Related]  

  • 11. Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors.
    Malamas MS; Farah SI; Lamani M; Pelekoudas DN; Perry NT; Rajarshi G; Miyabe CY; Chandrashekhar H; West J; Pavlopoulos S; Makriyannis A
    Bioorg Med Chem; 2020 Jan; 28(1):115195. PubMed ID: 31761726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
    Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
    J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Inflammatory Effects of Fucoxanthinol in LPS-Induced RAW264.7 Cells through the NAAA-PEA Pathway.
    Jin W; Yang L; Yi Z; Fang H; Chen W; Hong Z; Zhang Y; Zhang G; Li L
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32326173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation.
    Pontis S; Ribeiro A; Sasso O; Piomelli D
    Crit Rev Biochem Mol Biol; 2016; 51(1):7-14. PubMed ID: 26585314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain.
    Petrosino S; Ahmad A; Marcolongo G; Esposito E; Allarà M; Verde R; Cuzzocrea S; Di Marzo V
    Pharmacol Res; 2015 Jan; 91():9-14. PubMed ID: 25447594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent N-acylethanolamine-hydrolyzing acid amidase (NAAA) inhibitor as anti-inflammatory compounds.
    Li Y; Yang L; Chen L; Zhu C; Huang R; Zheng X; Qiu Y; Fu J
    PLoS One; 2012; 7(8):e43023. PubMed ID: 22916199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the development of β-lactams as N-Acylethanolamine Acid Amidase (NAAA) inhibitors: Synthesis and SAR study of new, potent N-O-substituted derivatives.
    Petracca R; Ponzano S; Bertozzi SM; Sasso O; Piomelli D; Bandiera T; Bertozzi F
    Eur J Med Chem; 2017 Jan; 126():561-575. PubMed ID: 27915171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
    Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
    Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acylethanolamine acid amidase (NAAA) inhibition decreases the motivation for alcohol in Marchigian Sardinian alcohol-preferring rats.
    Fotio Y; Ciccocioppo R; Piomelli D
    Psychopharmacology (Berl); 2021 Jan; 238(1):249-258. PubMed ID: 33037452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.